LIR-containing proteins in Mus musculus>> EXPORT DATA
S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component |
2001 | Q0VGY9 | 773 | 778 | LGYISV | 9 | membrane (GO:0016020) |
|||
2002 | Q0ZCJ7 | 339 | 344 | GSFDLL | 11 | nucleic acid binding (GO:0003676); protein binding (GO:0005515) |
nucleus (GO:0005634) |
||
2003 | Q0ZCJ7-2 | 204 | 209 | GSFDLL | 11 | ||||
2004 | Q148A4 | 240 | 245 | SDYLPV | 15 | ||||
2005 | Q148A4 | 251 | 256 | SDFLPV | 14 | ||||
2006 | Q148R4 | 561 | 566 | SEYLAL | 13 | ||||
2007 | Q14B48 | 1019 | 1024 | SGFDDL | 12 | ||||
2008 | Q14B48-2 | 829 | 834 | SGFDDL | 12 | ||||
2009 | Q14BK3 | 77 | 82 | KDFDKL | 15 | nucleus (GO:0005634) |
|||
2010 | Q14BK3-2 | 77 | 82 | KDFDKL | 15 | ||||
2011 | Q14DQ1 | 107 | 112 | KGYTAL | 11 | ||||
2012 | Q14DQ1-2 | 107 | 112 | KGYTAL | 11 | ||||
2013 | Q1ERP8 | 326 | 331 | SEFISV | 11 | immune system process (GO:0002376) |
|||
2014 | Q1ERP8-2 | 147 | 152 | PVFTEV | 6 | ||||
2015 | Q1ERP8-2 | 366 | 371 | SEFISV | 11 | ||||
2016 | Q1ERP8-3 | 191 | 196 | PVFTEV | 6 | ||||
2017 | Q1ERP8-3 | 410 | 415 | SEFISV | 11 | ||||
2018 | Q1ERP8-4 | 147 | 152 | PVFTEV | 6 | ||||
2019 | Q1ERP8-5 | 282 | 287 | SEFISV | 11 | ||||
2020 | Q20BD0 | 200 | 205 | RGFVFI | 13 | nucleotide binding (GO:0000166) |
ribonucleoprotein complex (GO:0030529) |
||
2021 | Q2KN98 | 290 | 295 | FGYQSL | 12 | CBL_HUMAN(800-805) FGWLSL(4) | cell adhesion (GO:0007155); cell cycle (GO:0007049); cell division (GO:0051301) |
||
2022 | Q2KN98 | 352 | 357 | EVYQPL | 8 | cell adhesion (GO:0007155); cell cycle (GO:0007049); cell division (GO:0051301) |
|||
2023 | Q2M3X8 | 523 | 528 | SDYVEV | 17 | nucleus (GO:0005634); synapse (GO:0045202) |
|||
2024 | Q2M3X8-2 | 516 | 521 | SDYVEV | 17 | ||||
2025 | Q2M3X8-3 | 585 | 590 | SDYVEV | 17 | ||||
2026 | Q2M3X8-4 | 592 | 597 | SDYVEV | 17 | ||||
2027 | Q2MHN3 | 1441 | 1446 | FGFELV | 11 | nucleus (GO:0005634) |
|||
2028 | Q2MHN3 | 1515 | 1520 | KSYDSL | 12 | nucleus (GO:0005634) |
|||
2029 | Q2QI47 | 3132 | 3137 | LGYDVL | 12 | ATG4B_HUMAN(6-11) LTYDTL(4) | protein binding (GO:0005515) |
response to stimulus (GO:0050896) |
stereocilium bundle (GO:0032421) |
2030 | Q2QI47-3 | 3132 | 3137 | LGYDVL | 12 | ATG4B_HUMAN(6-11) LTYDTL(4) | |||
2031 | Q2TB54 | 433 | 438 | PVWVSV | 13 | ||||
2032 | Q2TB54-2 | 489 | 494 | PVWVSV | 13 | ||||
2033 | Q2TBA9 | 65 | 70 | EEFQPV | 11 | protein binding (GO:0005515) |
nucleus (GO:0005634) |
||
2034 | Q2VPD4 | 540 | 545 | LGFDVL | 11 | protein binding (GO:0005515); signal transducer activity (GO:0004871) |
nucleus (GO:0005634); transcription factor complex (GO:0005667) |
||
2035 | Q32KG4 | 72 | 77 | PGFDSL | 11 | ||||
2036 | Q32KG4-2 | 72 | 77 | PGFDSL | 11 | ||||
2037 | Q3B7Z2 | 275 | 280 | RDFLML | 17 | lipid binding (GO:0008289) |
lipid transport (GO:0006869) |
||
2038 | Q3KNB6 | 30 | 35 | PEFELL | 12 | ||||
2039 | Q3KNI6 | 115 | 120 | PDYEIV | 16 | ||||
2040 | Q3KNJ2 | 266 | 271 | PEYEPV | 12 | nucleus (GO:0005634) |
|||
2041 | Q3KNJ2-2 | 200 | 205 | PEYEPV | 12 | ||||
2042 | Q3LAC4 | 1111 | 1116 | ASFTSI | 10 | ||||
2043 | Q3LIG2 | 105 | 110 | PSFDAL | 11 | protein binding (GO:0005515) |
nucleus (GO:0005634) |
||
2044 | Q3MI48 | 48 | 53 | SDWTHV | 21 | SQSTM_HUMAN(336-341) DDWTHL(4) | protein binding (GO:0005515) |
||
2045 | Q3MI99 | 335 | 340 | GSFDFL | 12 | extracellular matrix (GO:0031012); extracellular region (GO:0005576) |
|||
2046 | Q3T9A3 | 323 | 328 | ATYLLL | 11 | membrane (GO:0016020); nucleus (GO:0005634) |
|||
2047 | Q3T9T1 | 77 | 82 | AEYLKL | 12 | ||||
2048 | Q3T9X3 | 661 | 666 | DSYVAI | 15 | OPTN_HUMAN(176-181) DSFVEI(4) | protein binding (GO:0005515) |
||
2049 | Q3TA56 | 3 | 8 | PSFLVL | 11 | protein binding (GO:0005515) |
|||
2050 | Q3TBD2 | 82 | 87 | ATWTLV | 16 | intracellular (GO:0005622) |